January 16, 2025

FDA Clears Phase 2 Trial: Lorundrostat for OSA-Hypertension

Mineralys Therapeutics receives FDA clearance for a phase II clinical trial investigating lorundrostat, an aldosterone synthase inhibitor, in patients with moderate-to-severe obstructive sleep apnea and hypertension.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Updated TMS Guidelines for Depression Treatment

Explore the latest transcranial magnetic stimulation guidelines for depression, including updated protocols, safety data, and tailored recommendations for clinicians.

Conexiant

January 15, 2025

Can Wearables Help Manage Moderate Sleep Apnea Without CPAP?

Researchers are conducting the Moore4Medical trial to evaluate whether an eHealth intervention, consisting of a wrist device and a mobile application, can effectively manage blood pressure, sleep quality, and physical activity levels in adult patients with moderate obstructive sleep apnea and hypertension.

Conexiant

January 14, 2025

Anti-inflammatory Diets Modulate Neurotransmitter Production, Review Shows

"Everything we need for mental health comes from our food."

Conexiant

January 13, 2025

Depression Severity Linked to Malignant Glioma Risk

Severe depression linked to 27% higher malignant glioma risk, based on a nationwide cohort study.

Conexiant

January 13, 2025

TSPO Binding Links to Mood Disturbances

TSPO binding correlates with stress-linked mood and suicidal ideation in MDD, but causality remains uncertain.

Conexiant

January 10, 2025

Disparities in U.S. TBI Mortality: 2021 Analysis

Explore traumatic brain injury-related mortality trends.

Conexiant

January 09, 2025

Medicare Covers Tirzepatide for Sleep Apnea

Eli Lilly's tirzepatide gets Medicare coverage for sleep apnea, widening access to weight-loss treatment. Are obesity drugs getting a breakthrough?

Reuters